Table 5.
Genes that have a general association (P-value < 0.05) with the overall glioblastoma survival
Gene Symbol | Probe Identifier | P-value | Hazard Ratio1 | Relevant literature references |
---|---|---|---|---|
Tgfa | 205015_s_at | 0.0002 | 0.12 (0.04-0.37) | [28]G |
Sirpa | 202895_s_at | <.0001 | 0.24 (0.14-0.41) | [26]G |
Ctbp2 | 210835_s_at | <.0001 | 0.28 (0.16-0.48) | [101]O |
Eef1e1 | 213907_at | <.0001 | 0.37 (0.23-0.61) | [102]O |
Mapk3 | 212046_x_at | 0.0041 | 0.43 (0.24-0.76) | [103]O |
Actr2 | 200727_s_at | <.0001 | 0.43 (0.29-0.63) | [24]G |
Igh@ | 211637_x_at | 0.0167 | 0.44 (0.23-0.86) | n/a |
Plcg1 | 216551_x_at | <.0001 | 0.46 (0.31-0.68) | [26]G |
Mgat3 | 209764_at | <.0001 | 0.51 (0.37-0.71) | [26]G |
Lrp10 | 201412_at | 0.0041 | 0.60 (0.42-0.85) | [24]G |
Idh1 | 201193_at | 0.0051 | 0.60 (0.42-0.86) | [24]G |
Tmem8b | 207839_s_at | <.0001 | 0.60 (0.46-0.77) | n/a |
Ccna2 | 203418_at | <.0001 | 0.60 (0.49-0.75) | [104]O |
Topors | 204071_s_at | 0.0007 | 0.61 (0.46-0.81) | [26]G |
Rpl37a | 213459_at | 0.0164 | 0.66 (0.47-0.93) | [90]G |
Mdm2 | 217373_x_at | <.0001 | 0.69 (0.61-0.78) | [26]G |
E2f3 | 203693_s_at | 0.06722 | 0.75 (0.55-1.02) | [28]G |
Mdfic | 211675_s_at | 0.0006 | 0.78 (0.68-0.90) | [105]O |
Sod2 | 215078_at | <.0001 | 0.80 (0.73-0.88) | [25]G |
Akr1c3 | 209160_at | 0.0014 | 0.83 (0.73-0.93) | [26]G |
Thbs4 | 204776_at | 0.0007 | 1.18 (1.07-1.30) | [106]O |
Shc3 | 206330_s_at | 0.0031 | 1.32 (1.10-1.59) | [28]G |
Pik3r1 | 212249_at | 0.0145 | 1.34 (1.06-1.69) | [20]G |
Nkx2-5 | 206578_at | 0.0027 | 1.38 (1.12-1.70) | [107]O |
Hras | 212983_at | 0.0187 | 1.42 (1.06-1.90) | [85]G |
Bhlhb9 | 213709_at | 0.0192 | 1.42 (1.06-1.92) | [108]O |
C9orf95 | 219147_s_at | 0.0004 | 1.43 (1.17-1.73) | [109]O |
C17orf101 | 219254_at | 0.0085 | 1.46 (1.10-1.94) | [110]O |
Nol3 | 59625_at | <.0001 | 1.46 (1.21-1.76) | [111]O |
Rangap1 | 212125_at | 0.0225 | 1.47 (1.06-2.05) | [26]G |
Ftsj2 | 222130_s_at | 0.017 | 1.48 (1.07-2.05) | [112]O |
Rrm1 | 201476_s_at | 0.0006 | 1.49 (1.19-1.87) | [27]G |
Jag2 | 209784_s_at | 0.0351 | 1.63 (1.03-2.57) | [24]G |
Tnpo1 | 212635_at | 0.0054 | 1.89 (1.20-2.96) | n/a |
Myo7a | 211103_at | 0.0033 | 1.97 (1.25-3.10) | [113]O |
Actr2 | 200729_s_at | 0.0001 | 2.18 (1.47-3.23) | [24]G |
Csf1 | 209716_at | <.0001 | 2.33 (1.65-3.27) | [26]G |
Ank1 | 208352_x_at | 0.0003 | 2.38 (1.49-3.82) | [24]G |
B3galnt1 | 211379_x_at | <.0001 | 2.40 (1.76-3.28) | [114]O |
Kras | 214352_s_at | 0.002 | 2.44 (1.38-4.31) | [85]G |
Ewsr1 | 210012_s_at | 0.0005 | 2.49 (1.49-4.15) | [26]G |
Sec24c | 202361_at | <.0001 | 2.84 (1.76-4.60) | n/a |
Rpl10l | 217559_at | <.0001 | 2.95 (1.83-4.74) | [115]O |
Ighg1 | 211908_x_at | 0.0007 | 3.41 (1.68-6.93) | [116]O |
Ighg1 | 211693_at | 0.0007 | 4.33 (1.86-10.04) | [116]O |
n/a, No association with any type of cancer found in literature;
1 Hazard ratio estimate (95% confidence interval);
2 Borderline significant (P-value < 0.1) included for completeness;
G Gene confirmed in an independent glioblastoma multiforme study; the number between square brackets denotes the corresponding literature reference;
O Gene confirmed in an independent study on any other type of cancer; the number between square brackets denotes the corresponding literature reference.